Viewing Study NCT04334993

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:18 AM
Ignite Modification Date: 2026-06-24 @ 11:15 PM
Study NCT ID: NCT04334993
Status: UNKNOWN
Last Update Posted: 2021-05-07
First Post: 2020-03-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
Sponsor: Israeli Medical Association
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Philadelphia-Negative ALL View
None High-Risk Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Philadelphia-Negative ALL View
None Pediatric therapy View
None Blinatumomab View
None Allogeneic transplantation View